Novartis · 2 weeks ago
Associate Director, Market Access Portfolio Strategy
United States
Full-time
Remote
Lead/Staff
$160K/yr - $298K/yr
5+ years expNovartis Pharmaceuticals Corporation is a leading company in the healthcare sector, and they are seeking an Associate Director for their Market Access Portfolio Strategy team. The role involves understanding key market dynamics, supporting forecasting efforts, and ensuring effective communication of market insights across the organization.
BiotechnologyHealthcarePharmaceuticalMedical DeviceHealth CareMedicalPrecision Medicine
Responsibilities
Ensure that the Market Access Early Pipeline team forecasting model assumptions are kept current by developing a deep understanding of and updating the data assumptions that underpin many of the calculations on a regular basis
Catalogue market trends that we track to ensure that the list is complete, assumptions are current, and trends are effectively communicated across the US Market Access organization and relevant cross-functional stakeholders
Work with Directors, Market Portfolio Strategy to support ongoing market analyses by gathering data and insights and using these findings to inform methodologies and story development
Draft and communicate updates to the US Market Access Outlook and ensure content from the US Market Access Outlook gets repurposed and used across the organization. Gather and maintain a meaningful catalogue of above-brand initiatives being performed across the US Market Access organization so that the Market Access Leadership Team can ensure appropriate visibility and participation across the organization
Present findings from analyses at various levels across the organization
Participate in development of relevant market research, including learning and following all internal processes, analyzing secondary data, and incorporating internal Novartis experience to inform insights
Organize the annual business planning process for the team
Qualification
Required
Bachelor's degree required; MBA, Health Policy, or equivalent preferred
Minimum of 5 years of pharmaceutical experience in Market Access, Healthcare Strategy Consulting, Policy, Managed Care Finance, Insights & Analytics or Business Development. 3+ years with direct US Market experience is preferred
Demonstrated familiarity with and ability to manipulate industry standard claims and/or payer data (e.g. IQVIA, DRG Fingertip Formulary), or other published sources of price and payer coverage information
Strong interpersonal, communication, and influencing skills combined with an ability to successfully collaborate across a matrix organization
Demonstrated prioritization, organizational, and analytical skills as well as the ability to create solutions for complex processes and procedures
Ability to analyze complex business issues and trends and to connect commercial, financial, and clinical perspectives to develop enhanced value propositions
Demonstrated high degree of emotional intelligence, adaptability, and creativity
Preferred
MBA, Health Policy, or equivalent preferred
3+ years with direct US Market experience is preferred
Benefits
Performance-based cash incentive
Eligibility to be considered for annual equity awards
Comprehensive benefits package that includes health, life and disability benefits
A 401(k) with company contribution and match
A variety of other benefits
Generous time off package including vacation, personal days, holidays and other leaves
Company
Novartis
Novartis is a pharmaceutical company that researches and develops medicines for serious diseases to improve and extend people's lives. It is a sub-organization of Meye Asset Management.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$4.49BKey Investors
Bill & Melinda Gates Foundation
2026-05-13Post Ipo Debt· $1.99B
2024-06-19Post Ipo Debt· $2.49B
2018-02-14Grant· $6.5M
Leadership Team
Mukul Mehta
Chief Financial Officer, Member of the Executive Committee
Daniel Grant
Vice President & Global Program Head
Recent News
2026-07-12
Genetic Engineering News
2026-07-10
Seattle TechFlash
2026-07-10
Company data provided by crunchbase